Gastric/Esophageal Adenocarcinoma
1 clinical trials · Condition
◉ Watch Gastric/Esophageal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types (NCT00633789) | Bristol-Myers Squibb | 2008-06-01 |
Track Gastric/Esophageal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.